Regeneron (REGN) - News Mentions

Sign up to add (REGN) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 3 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Janney Montgomery Scott LLC Lowers Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
November 6
Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
November 6
US Bancorp DE Cuts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
November 5
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
November 4
Regeneron Pharmaceuticals Inc. stock rises Tuesday, still underperforms market
November 4
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
November 3
Law Offices of Howard G. Smith Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
November 3
Regeneron: Buying A Promising Pipeline At A Fair Price (Rating Upgrade)
November 3
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
November 3
Barclays Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,065.00
November 3
Regeneron price target lowered to $1,126 from $1,137 at Truist
November 2
The Law Offices of Frank R. Cruz Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
November 1
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
October 31
Regeneron Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
October 31
Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
October 31
Regeneron price target lowered by $11 at Truist, here's why
October 31

Month over Month

Est. daily news mentions.

Oct 2024 1
Sep 2024 1
Aug 2024 1
Jul 2024 1
Jun 2024 1

How often is Regeneron mentioned in the news?

Regeneron was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Regeneron performing compared to its industry peers?

Regeneron underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Regeneron in the last month?

Regeneron's was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Regeneron?

By monitoring mentions in the news for Regeneron, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Regeneron, ultimately improving their investment strategies.

Sign up and get more insights on Regeneron.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact